These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9614520)

  • 1. What effect does laser photocoagulation have on driving visual fields in diabetics?
    Pearson AR; Tanner V; Keightley SJ; Casswell AG
    Eye (Lond); 1998; 12 ( Pt 1)():64-8. PubMed ID: 9614520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How good are we at assessing driving visual fields in diabetics?
    Pearson AR; Keightley SJ; Casswell AG
    Eye (Lond); 1998; 12 ( Pt 6)():938-42. PubMed ID: 10325990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term review of driving potential following bilateral panretinal photocoagulation for proliferative diabetic retinopathy.
    Vernon SA; Bhagey J; Boraik M; El-Defrawy H
    Diabet Med; 2009 Jan; 26(1):97-9. PubMed ID: 19125769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fields, DVLC and panretinal photocoagulation.
    Buckley SA; Jenkins L; Benjamin L
    Eye (Lond); 1992; 6 ( Pt 6)():623-5. PubMed ID: 1289141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How much blame can be placed on laser photocoagulation for failure to attain driving standards?
    Mackie SW; Webb LA; Hutchison BM; Hammer HM; Barrie T; Walsh G
    Eye (Lond); 1995; 9 ( Pt 4)():517-25. PubMed ID: 7498578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altering the pattern of panretinal photocoagulation: could the visual field for driving be preserved?
    Davies N
    Eye (Lond); 1999 Aug; 13 ( Pt 4)():531-6. PubMed ID: 10692925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of laser photocoagulation in patients with diabetic retinopathy developed as a complication of diabetes type 2].
    Wilczyński M; Dzivgielewski K
    Klin Oczna; 2006; 108(1-3):66-9. PubMed ID: 16883944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red krypton and blue-green argon panretinal laser photocoagulation for proliferative diabetic retinopathy: a laboratory and clinical comparison.
    Blankenship GW
    Trans Am Ophthalmol Soc; 1986; 84():967-1003. PubMed ID: 2438841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The loss of visual field after proliferative diabetic retinopathy treatment with two different techniques of panretinal photocoagulation].
    Kovacić Z; Ivanisević M; Karelović D
    Acta Med Croatica; 2007 Apr; 61(2):149-52. PubMed ID: 17585469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Multispot Laser Panretinal Photocoagulation on Retinal Sensitivity and Driving Eligibility in Patients With Diabetic Retinopathy.
    Subash M; Comyn O; Samy A; Qatarneh D; Antonakis S; Mehat M; Tee J; Mansour T; Xing W; Bunce C; Viswanathan A; Rubin G; Weleber R; Peto T; Wickham L; Michaelides M
    JAMA Ophthalmol; 2016 Jun; 134(6):666-72. PubMed ID: 27077924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subthreshold diode micropulse panretinal photocoagulation for proliferative diabetic retinopathy.
    Luttrull JK; Musch DC; Spink CA
    Eye (Lond); 2008 May; 22(5):607-12. PubMed ID: 17293791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual prognosis after panretinal photocoagulation for proliferative diabetic retinopathy.
    Bek T; Erlandsen M
    Acta Ophthalmol Scand; 2006 Feb; 84(1):16-20. PubMed ID: 16445434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated perimetric changes following panretinal photocoagulation in diabetic retinopathy.
    Khosla PK; Gupta V; Tewari HK; Kumar A
    Ophthalmic Surg; 1993 Apr; 24(4):256-61. PubMed ID: 8321507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in the visual field and dark adaptation following panretinal photocoagulation in diabetic retinopathy].
    Prskavec FH; Fulmek R; Klemen C; Stelzer N
    Klin Monbl Augenheilkd; 1986 Nov; 189(5):385-7. PubMed ID: 2433497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Passing the DVLA field regulations following bilateral macular photocoagulation in diabetics.
    Tong L; Vernon SA
    Eye (Lond); 2000 Feb; 14 ( Pt 1)():35-8. PubMed ID: 10755097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of argon laser photocoagulation on diabetic retinopathy].
    Wei ZY; Hu SX; Tang N; Wu J; Wang J
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1313-5. PubMed ID: 15567792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photocoagulation in diabetic retinopathy. A multicentre study in Sweden.
    Stenkula S
    Acta Ophthalmol Suppl; 1984; 162():1-100. PubMed ID: 6324526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDR in juvenile onset diabetics: high-risk proliferative diabetic retinopathy in juvenile onset diabetics.
    Singerman LJ; Weaver DT
    Retina; 1981; 1(1):18-26. PubMed ID: 15633405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of laser spot diameter on the reproducibility of visual field analysis in diabetic patients with upper temporal retinal vein occlusion.
    Akar Y; Apaydin KC; Metinsoy M
    Ophthalmologica; 2008; 222(2):64-8. PubMed ID: 18303224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of conventional argon panretinal laser photocoagulation on retinal nerve fibre layer and driving visual fields in diabetic retinopathy.
    Muqit MM; Wakely L; Stanga PE; Henson DB; Ghanchi FD
    Eye (Lond); 2010 Jul; 24(7):1136-42. PubMed ID: 20019760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.